There Is Clear Momentum For Adial Pharmaceuticals Inc (NASDAQ: ADIL)
Adial Pharmaceuticals Inc (ADIL) concluded trading on Thursday at a closing price of $0.41, with 6.63 million shares of worth about $2.72 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -61.99% during that period and on July 10, 2025 the price saw a […]
Adial Pharmaceuticals Inc (ADIL): Street Finally Waking Up
Currently, there are 15.78M common shares owned by the public and among those 15.50M shares have been available to trade. The company’s stock has a 5-day price change of -29.47% and -67.70% over the past three months. ADIL shares are trading -79.15% year to date (YTD), with the 12-month market performance down to -77.30% lower. […]
Now Is A Suitable Moment For A Long-Term Purchase Of Adial Pharmaceuticals Inc (NASDAQ: ADIL)
Currently, there are 10.43M common shares owned by the public and among those 10.25M shares have been available to trade. The company’s stock has a 5-day price change of -59.49% and -67.35% over the past three months. ADIL shares are trading -76.18% year to date (YTD), with the 12-month market performance down to -81.46% lower. […]
Adial Pharmaceuticals Inc (ADIL) Outlook Starting To Look Brighter?
Adial Pharmaceuticals Inc (ADIL) concluded trading on Wednesday at a closing price of $0.45, with 13.83 million shares of worth about $6.22 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -62.27% during that period and on June 11, 2025 the price saw a […]
There Is Clear Momentum For Adial Pharmaceuticals Inc (NASDAQ: ADIL)
Adial Pharmaceuticals Inc (ADIL) concluded trading on Wednesday at a closing price of $1.14, with 7.48 million shares of worth about $8.53 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -70.33% during that period and on Wednesday the price saw a loss of […]